News Daily News Long-term Anticoagulation After Unprovoked VTE: New Insights Shelley Wood September 13, 2021
News Conference News ACC 2021 ACTION: Full-Dose Rivaroxaban Doesn’t Help in Hospitalized COVID-19 Todd Neale May 17, 2021
News Daily News VTE Risk Higher After Oxford/AstraZeneca COVID-19 Vaccine, Study Affirms Todd Neale May 06, 2021
News Daily News VTE Related to SARS-CoV-2 Infection Less of a Problem in Outpatients Todd Neale April 06, 2021
News Daily News INSPIRATION: No Dip in COVID-19 Deaths or Thromboses With Higher Anticoagulation Dose L.A. McKeown March 19, 2021
News Daily News Antithrombotic Therapy for COVID-19: Challenges and Lessons for the Future L.A. McKeown March 17, 2021
News Features The Right Anticoagulation Dose in COVID-19? Final Answer Remains Elusive Todd Neale February 08, 2021
News Daily News ACC Issues New Guidance Around Antithrombotic Choices in A-fib, VTE Todd Neale December 22, 2020
News Daily News Thrombotic Events Frequent Among COVID-19 Patients in ICUs Michael O'Riordan October 27, 2020
News Daily News New AHA Guidance on Hospital VTE Stresses Risk Assessment, Standardization Yael L. Maxwell May 12, 2020
News Daily News How COVID-19 Promotes Thrombosis, Posing Problems for Drug-Drug Interactions Michael O'Riordan April 22, 2020
News Conference News ESC 2019 ESC Updates Guidance on Management of Acute Pulmonary Embolism Todd Neale September 06, 2019
News Daily News FDA Approves Dalteparin Sodium as First Anticoagulant For Use in Pediatric VTE Patients Yael L. Maxwell May 16, 2019